These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 19438131)

  • 1. Relationship between anti-acetylcholine receptor antibody titres and severity of myasthenia gravis.
    Aurangzeb S; Tariq M; Irshad M; Badshah M; Khan RS
    J Pak Med Assoc; 2009 May; 59(5):289-92. PubMed ID: 19438131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between Low and High Anti-acetylcholine Receptor Antibody Titers and Clinical Severity in Myasthenia Gravis.
    Ullah U; Iftikhar S; Javed MA
    J Coll Physicians Surg Pak; 2021 Aug; 31(8):965-968. PubMed ID: 34320716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antibodies in myasthenia gravis].
    Eymard B
    Rev Neurol (Paris); 2009 Feb; 165(2):137-43. PubMed ID: 19162288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical Utility of Acetylcholine Receptor Antibody Testing in Ocular Myasthenia Gravis.
    Peeler CE; De Lott LB; Nagia L; Lemos J; Eggenberger ER; Cornblath WT
    JAMA Neurol; 2015 Oct; 72(10):1170-4. PubMed ID: 26258604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Remarkably increased resistin levels in anti-AChR antibody-positive myasthenia gravis.
    Zhang DQ; Wang R; Li T; Li X; Qi Y; Wang J; Yang L
    J Neuroimmunol; 2015 Jun; 283():7-10. PubMed ID: 26004149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors affecting outcome in ocular myasthenia gravis.
    Mazzoli M; Ariatti A; Valzania F; Kaleci S; Tondelli M; Nichelli PF; Galassi G
    Int J Neurosci; 2018 Jan; 128(1):15-24. PubMed ID: 28625092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The predictive value of the presence of different antibodies and thymus pathology to the clinical outcome in patients with generalized myasthenia gravis.
    Nikolic A; Djukic P; Basta I; Hajdukovic Lj; Stojanovic VR; Stevic Z; Nikolic D; Bozic V; Lavrnic S; Lavrnic D
    Clin Neurol Neurosurg; 2013 Apr; 115(4):432-7. PubMed ID: 22770539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acetylcholine receptor antibody titer, sensitivity to curare electromyogram and disease severity in myasthenia gravis].
    Chen SM
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Jun; 24(3):169-73, 189. PubMed ID: 1889330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome of children with acetylcholine receptor (AChR) antibody positive juvenile myasthenia gravis following thymectomy.
    Heng HS; Lim M; Absoud M; Austin C; Clarke D; Wraige E; Reid C; Robb SA; Jungbluth H
    Neuromuscul Disord; 2014 Jan; 24(1):25-30. PubMed ID: 24239058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acetylcholine receptor antibodies in patients with myasthenia].
    Neretin VIa; Kotov SV; Gekht BM; Agafonov BV; Lokhmiuller G; Sidorova OP; Sepp EK; Shcherbakova NI; Kalinenkova SG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(3):51-3. PubMed ID: 11957349
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterogeneity of antibodies directed against the alpha-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis.
    Vernet-der Garabedian B; Morel E; Bach JF
    J Neuroimmunol; 1986 Jul; 12(1):65-74. PubMed ID: 3711314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of acetylcholine receptor antibodies in myasthenia gravis].
    Zeitlhofer J; Maida EM; Mamoli B; Mayr N
    Wien Med Wochenschr; 1986 Jul; 136(13):329-32. PubMed ID: 3765651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical manifestations of acetylcholine receptor antibody positive and negative myasthenia gravis.
    Pasutharnchat N; Wacharapluesadee S; Hemachudha T
    J Med Assoc Thai; 2012 Mar; 95(3):313-9. PubMed ID: 22550827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MRI and clinical studies of facial and bulbar muscle involvement in MuSK antibody-associated myasthenia gravis.
    Farrugia ME; Robson MD; Clover L; Anslow P; Newsom-Davis J; Kennett R; Hilton-Jones D; Matthews PM; Vincent A
    Brain; 2006 Jun; 129(Pt 6):1481-92. PubMed ID: 16672291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acetylcholine receptor antibody in Thai generalized myasthenia gravis patients.
    Jitpimolmard S; Taimkao S; Chotmongkol V; Sawanyawisuth K; Vincent A; Newsom-Davis J
    J Med Assoc Thai; 2006 Jan; 89(1):68-71. PubMed ID: 16583584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T-cell recognition of acetylcholine receptor provides a reliable means for monitoring autoimmunity to acetylcholine receptor in antibody-negative myasthenia gravis patients.
    Oshima M; Deitiker PR; Smith RG; Mosier D; Atassi MZ
    Autoimmunity; 2012 Mar; 45(2):153-60. PubMed ID: 21985279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The high frequency and clinical feature of seronegative myasthenia gravis in Southern China.
    Feng HY; Wang HY; Liu WB; He XT; Huang X; Luo CM; Li Y
    Neurol Sci; 2013 Jun; 34(6):919-24. PubMed ID: 22829131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Characteristics of Patients With Double-Seronegative Myasthenia Gravis and Antibodies to Cortactin.
    Cortés-Vicente E; Gallardo E; Martínez MÁ; Díaz-Manera J; Querol L; Rojas-García R; Illa I
    JAMA Neurol; 2016 Sep; 73(9):1099-104. PubMed ID: 27379450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Humoral immunity in myasthenia gravis: biochemical characterization of acquired antireceptor antibodies and clinical correlations.
    Tindall RS
    Ann Neurol; 1981 Nov; 10(5):437-47. PubMed ID: 7305297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.